Stefan Heller - 10 Jun 2021 Form 3 Insider Report for Janux Therapeutics, Inc. (JANX)

Role
Director
Signature
/s/ Tighe Reardon, Attorney-in-Fact
Issuer symbol
JANX
Transactions as of
10 Jun 2021
Net transactions value
$0
Form type
3
Filing time
10 Jun 2021, 19:10:06 UTC
Next filing
16 Jun 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding JANX Common Stock 96,075 10 Jun 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.